Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Solazyme (SZYM): It doesn't have a great balance sheet and it doesn't make a lot of money, said Cramer. Don't buy.

: I think this is a froth stock, said Cramer. It's moved up too much.

Chelsea Therapeutics (CHTP): I like this as a spec, said Cramer. It's a play on Rheumatoid Arthritis.

InvenSense (INVN): It's a play on motion detection, said Cramer. It's been bid up but now it needs big contracts, said Cramer. Without big contracts I think it gives up the ghost.

Zynga (ZNGA): I don't think it's done going up, said Cramer. I think it can still go higher.

Bob Evans Farms (BOBE): I think it's a great company, said Cramer, but it had a terrible quarter. However, I wouldn't sell down here.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com